Sampre Nutritions Ltd - Stock Valuation and Financial Performance

BSE: 530617 | NSE: | Consumer Food | Small Cap

Sampre Nutritions Share Price

68.96 -3.13 -4.34%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Sampre Nutritions

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Sampre Nutritions stock performance -

mw4me loader
P/E Ratio (SA):
110.89
Market Cap:
123.9 Cr.
52-wk low:
50.2
52-wk high:
101.2

Is Sampre Nutritions Ltd an attractive stock to invest in?

1. Is Sampre Nutritions Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sampre Nutritions Ltd is a below average quality company.

2. Is Sampre Nutritions Ltd undervalued or overvalued?

The key valuation ratios of Sampre Nutritions Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Sampre Nutritions Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sampre Nutritions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sampre Nutritions:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sampre Nutritions Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 6.1%11.1%8.8%7.1%8.7%8.5%5.3%6.7%6.6%6.4%-
Value Creation
Index
-0.6-0.2-0.4-0.5-0.4-0.4-0.6-0.5-0.5-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.145.133.632.728.724.918.223.137.125.224
Sales YoY Gr.-346.9%-25.5%-2.8%-12.2%-13.4%-26.6%26.9%60.4%-32.2%-
Adj EPS 0.51.90.90.50.50.70.20.70.50.40.6
YoY Gr.-293.6%-49.2%-46.8%0%42%-77.5%318.8%-23.9%-15.7%-
BVPS (₹) 17.819.620.420.921.522.222.42327.428.346
Adj Net
Profit
0.20.90.50.20.20.30.10.30.40.31
Cash Flow from Ops. -0.31.2-11.55.72.6-0.22.40.94-
Debt/CF from Ops. -11.46.6-12.69.43.57.8-119.88.819.14.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 10.7%-2.6%11.3%-32.2%
Adj EPS -1%-3%39%-15.7%
BVPS5.3%5.7%8.1%3.3%
Share Price 20.5% 30.7% 30.5% -2.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
2.79.94.72.42.43.20.732.21.41.7
Op. Profit
Mgn %
18.36.28.99.313.115.718.815.210.916.722.1
Net Profit
Mgn %
2.221.40.70.91.40.41.40.91.24.7
Debt to
Equity
0.50.81.31.41.91.921.90.90.90.4
Working Cap
Days
20571119128160192277241168268131
Cash Conv.
Cycle
11733567773621251309315741

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 11.32%

Net Profit is growing at healthy rate in last 3 years 39.03%

Debt to equity has declined versus last 3 years average to 0.85

Return on Equity has declined versus last 3 years average to 1.70%

Sales growth is not so good in last 4 quarters at -25.30%

Latest Financials - Sampre Nutritions Ltd.

Standalone Consolidated
TTM EPS (₹) 0.6 0.1
TTM Sales (₹ Cr.) 23.5 25.2
BVPS (₹.) 46 45.9
Reserves (₹ Cr.) 63 65
P/BV 1.50 1.50
PE 110.89 533.90
From the Market
52 Week Low / High (₹) 50.15 / 101.17
All Time Low / High (₹) 1.05 / 296.35
Market Cap (₹ Cr.) 124
Equity (₹ Cr.) 18
Face Value (₹) 10
Industry PE 64.6

Management X-Ray of Sampre Nutritions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Sampre Nutritions

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales10453433292518233725
Operating Expenses 8423130252115203321
Manufacturing Costs510774108101412
Material Costs130212018847155
Employee Cost 0001111111
Other Costs 1222222233
Operating Profit 2333443344
Operating Profit Margin (%) 16.9%6.1%8.9%9.3%13.0%15.7%18.8%15.1%10.9%16.7%
Other Income 0000000000
Interest 0111222222
Depreciation 1111112222
Exceptional Items 0000000000
Profit Before Tax 0110000001
Tax 0000000000
Profit After Tax 0100000000
PAT Margin (%) 1.3%1.9%1.3%0.7%0.8%1.4%0.4%1.3%0.9%1.2%
Adjusted EPS (₹)0.31.80.90.50.50.70.20.60.50.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 991010101111111921
Share Capital 5555555577
Reserves 455566661213
Minority Interest0000000000
Debt371313181921211516
Long Term Debt247911111213119
Short Term Debt2464788856
Trade Payables1422655442
Others Liabilities 3312332266
Total Liabilities 17242627383738384445

Fixed Assets

Gross Block22222329333734404042
Accumulated Depreciation12131416171916171921
Net Fixed Assets109913151918222121
CWIP 0462955045
Investments 0000000000
Inventories1245677778
Trade Receivables4655546677
Cash Equivalents 0000010000
Others Assets2232322244
Total Assets 17242627383738384445

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 01-11630214
PBT 0110000001
Adjustment 2222323344
Changes in Working Capital -2-1-4-13-0-3-1-3-0
Tax Paid 0000000000
Cash Flow From Investing Activity -1-4-3-2-10-1-1-1-4-4
Capex -1-4-3-2-10-1-1-1-4-4
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 13405-10-230
Net Proceeds from Shares 00000000101
Net Proceeds from Borrowing 12333-111-2-1
Interest Paid 0-1-10-1-1-1-2-2-2
Dividend Paid 0000000000
Others 022-2310-1-22
Net Cash Flow 000001-1000
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)1.529.534.692.432.273.190.72.812.321.57
ROCE (%)6.0911.148.797.068.718.455.266.656.576.38
Asset Turnover Ratio0.652.231.341.220.880.660.480.610.910.57
PAT to CFO Conversion(x)N/A1N/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days1283959526163989666103
Inventory Days26163348699514311470106
Payable Days2263152347724247624092215

Sampre Nutritions Ltd Stock News

Sampre Nutritions Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Sampre Nutritions on 20-Dec-2024 16:59 is ₹68.96.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Sampre Nutritions stood at ₹123.9.
The latest P/E ratio of Sampre Nutritions as of 20-Dec-2024 16:59 is 110.9.
The latest P/B ratio of Sampre Nutritions as of 20-Dec-2024 16:59 is 1.50.
The 52-week high of Sampre Nutritions is ₹101.2 and the 52-week low is ₹50.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sampre Nutritions is ₹23.54 ( Cr.) .

About Sampre Nutritions Ltd

Sampre Nutritions was incorporated on December 3, 1991 as a Public company.  Lately it was converted into a public limited company in 16 May 1994.  The company is engaged in the manufacture and sale of sugar-boiled candies and toffees.

The multi-locational facilities of the Group are equipped with APV Baker 4 bank Deposited Line, New generation imported Uni plast lines cut & wrap lines, Cooling equipment and Packing machines. Continuous investments in the latest technology for each of the product lines have ensured the highest global standards. Supporting quality and optimum productivity across the integrated network are world-class laboratories and a strong R&D. The R&D also provides a one-stop source for everything from development to delivery of products to exacting international standards.

The company’s registered office is located at Kiran Arcade, 3 Floor, 100 Sarojini Devi Road Secunderabad,Andhra Pradesh-500003 .

Clientele

  • PROCTER & GAMBLE INDIA LTD  
  • WARNER LAMBERT INDIA LTD
  • CADBURY INDIA LIMITED 
  • INDIAN AIRLINES LTD 
  • RANBAXY LABORATORIES LTD 
  • KNOLL PHARMACEUTICALS LTD (BOOTS) 
  • CIPLA LIMITED
  • DABUR INDIA LIMITED
  • AMRUTANJAN LIMITED
  • AUROBINDO PHARMA LIMITED
  • ANCHOR HEALTH & BEAUTY CARE PVT LTD
  • Dr. MOREPEN LABORATORIES LTD
  • HIMALAYA DRUG COMPANY
  • BAIDYANATH AYURVED BHAVAN PVT LTD
  • ELDER PHARMACEUTICALS LTD
  • MICRONUTRIENT, CANADA
  • ITC LIMITED

Awards and Achievements

The quality initiatives have credited the Group with many coveted citations viz., Pinnacle Awards by P&G, USA for Outstanding Quality Assurance Standards for 2 consecutive years, and the Golden Peacock National Quality Award in 1998 for Outstanding Quality Efforts in Small Sector Manufacturing.

The Rajiv Gandhi National Quality Award given by the Govt. of India and an ISO 9002 certification was topped by Sampre becoming the first confectionery Company in South East Asia to receive HACCP certification - the highest quality certification from BVQI –Netherlands for the Food industry.


  •  
  • Read More Read Less
    You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
    © 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.